Tag: DPA

Leica Biosystems Applauds FDA Primary Diagnosis Clearance as a Step Forward in Clinical Acceptance of Digital Pathology

| May 11, 2017 | 0 Comments

VISTA, CA – May 11, 2017 – The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging (WSI) system (Philips IntelliSite™ Pathology Solution) for review of digital surgical pathology slides. Leica Biosystems congratulates both the FDA and the Digital Pathology Association (DPA) on this positive outcome from […]

Continue Reading

DPA Companion Meeting to Take Place at 2017 Pathology Informatics Summit

| April 1, 2017 | 0 Comments

SAVE THE DATE! DPA COMPANION MEETING To take place at the 2017 Pathology Informatics Summit Monday, May 22, 2017 | 5:00-7:00 PM Wyndham Grand Pittsburgh Hotel | King’s Garden 2/3 Pittsburgh, PA Presentations Include: Quantitative Image Analysis for HER2 Immunohistochemistry for Breast Cancer: Guideline Update and – Review of Draft Recommendations by Dr. Marilyn Bui Primary Diagnosis […]

Continue Reading

Register Now for Upcoming Digital Pathology Association Webinar

| January 22, 2017 | 0 Comments

What to Expect for the Future of Regulatory Thursday, January 26, 2017 | 1 – 2 PM EST Presenter: Esther Abels Director Quality & Regulatory and Medical Affairs Philips Presentation Overview: Digital pathology is seen as bringing flexibility in the workflow and facilitating the pathologist to easier share information. DP has the potential to enhance cancer […]

Continue Reading

DPA Announces New President & Board Representatives

| December 14, 2016 | 0 Comments

Congratulations to Eric, Junya, Michael and Kevin for their recent appointments to the DPA Board! The Digital Pathology Association (DPA) is pleased to acknowledge Dr. Eric Glassy of Affiliated Pathologists Medical Group (APMG) as the Association’s President in 2017. Dr. Glassy was elected to the DPA Board in December, 2010 and has since served as […]

Continue Reading

Pathology Visions 2016 Room Block Closes Today!

| September 23, 2016 | 0 Comments

Don’t forget to reserve your room for Pathology Visions 2016! The DPA has secured a discounted room rate for attendees of Pathology Visions 2016 at the Manchester Grand Hyatt. The Pathology Visions room block will close today – Friday, September 23, 2016. MANCHESTER GRAND HYATT 1 Market Place San Diego, CA 92101 (619) 232-1234 manchestergrand.hyatt.com Why Attend Pathology […]

Continue Reading

Learn About the Clinical Track at Pathology Visions 2016

| August 4, 2016 | 0 Comments

 CLINICAL TRACK OVERVIEW The clinical track at this year’s Pathology Visions will feature presentations and workshops by national and global leaders with experience and understanding of implementation of digital pathology solutions and the challenges and barriers they faced and are facing as they roll out these solutions to their environment. This track will also feature […]

Continue Reading

Proposal Deadline Extended for Pathology Visions 2016

| May 15, 2016 | 0 Comments

PROPOSAL DEADLINE EXTENDED! Showcase Your Expertise by Presenting at Pathology Visions 2016 Benefits of Presenting: Complimentary Travel & Registration: If you are selected to present, you will receive a complimentary registration to the conference, and your flight and hotel will be paid for by the DPA. Dedicated Presentation Format: An oral presentation session will allow for […]

Continue Reading

Resident Travel Awards Available from Digital Pathology Association for Pathology Visions 2016

| May 14, 2016 | 0 Comments

Apply Today! Want to Attend Pathology Visions 2016 for Free? The DPA is making up to three conference travel awards available ($2,000 value each) for pathology residents and fellows to attend Pathology Visions 2016. The travel award funding is intended to defray costs of registration and travel expenses. Recipients will be chosen based on their understanding of the impact […]

Continue Reading

FDA’s Technical Performance Assessment of Digital Pathology Whole Slide Imaging Devices

| May 10, 2016 | 0 Comments

WHAT DOES IT MEAN TO ME? The Digital Pathology Association 2016 Webinar Series – Session 2 Available to Members Only Thursday, May 25, 2016 | 1pm EST Learn more about the newly released FDA Guidance for Technical Performance Assessment of Digital Pathology Whole Slide Imaging Devices. What does it mean to you? Members of the DPA […]

Continue Reading

The Unleashed Power of Digital Pathology: Is There a Way Forward?

| March 29, 2016 | 0 Comments

The featured post for today is guest written by Dr. Anil Parwani, known throughout the industry as a key opinion leader and has been very active in digital pathology among many other professional and research interests. In his post he looks back 15 years to our first meeting at a pathology meeting, perhaps in a […]

Continue Reading

Scholarship Offered by Digital Pathology Association

| February 25, 2016 | 0 Comments

The DPA, offers a scholarship intended to support the advancement of knowledge and continuing education in digital pathology. It is presented to a National Society for Histotechnology (NSH) member certified in histology, and currently utilizing Whole Slide Imaging (WSI) in the clinical or research laboratory. The amount of the scholarship is $1,500 and is to be […]

Continue Reading

Digital Pathology Association Acknowledges Collaborative Efforts with FDA for Whole Slide Imaging

| February 20, 2016 | 0 Comments

The Digital Pathology Association (DPA) recently announced its suggestion that digital pathology manufacturers currently interested in marketing Whole Slide Imaging (WSI) devices for primary diagnosis in the United States submit de novo applications to the Food and Drug Administration (FDA) based on clarity and guidance provided to the DPA from the FDA. WSI technology is critical to advancement […]

Continue Reading

Omnyx Applauds FDA and Digital Pathology Association on Recent Collaboration 

| January 17, 2016 | 0 Comments

Last week news was released after months of speculation, that the FDA would consider the de novo classification option for digital pathology systems as a pathway for bringing to market a moderate or low risk device which has not yet been classified, and for which there is no predicate device (as in whole slide imaging systems). If the FDA […]

Continue Reading

DPA Recommends Whole Slide Imaging Manufacturers Submit De Novo Applications to the FDA for Primary Diagnosis

| January 14, 2016 | 0 Comments

Collaboration with FDA Results in Opportunity for Streamlined Approval Process The Digital Pathology Association (DPA) announced today that it suggests digital pathology manufacturers currently interested in marketing whole slide imaging (WSI) devices for primary diagnosis in the United States submit de novo applications to the Food and Drug Administration (FDA). WSI is a technology which […]

Continue Reading